Literature DB >> 12170840

Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.

Catherine Brière1.   

Abstract

A 7-year-old, neutered, male Labrador retriever was diagnosed with a tarsometatarsal grade II mast cell tumor. Metastasis was identified in the popliteal lymph node. Amputation was not an option. A reverse saphenous skin flap was used to cover the skin defect caused by excision of the tumor. Surgery was followed with adjunctive chemotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12170840      PMCID: PMC339404     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  6 in total

1.  Clinical evaluation of axial pattern skin flaps in dogs and cats: 19 cases (1981-1990).

Authors:  P B Trevor; M M Smith; D R Waldron; C S Hedlund
Journal:  J Am Vet Med Assoc       Date:  1992-08-15       Impact factor: 1.936

2.  Treatment of canine mast cell tumors with CCNU (lomustine).

Authors:  K M Rassnick; A S Moore; L E Williams; C A London; P P Kintzer; S J Engler; S M Cotter
Journal:  J Vet Intern Med       Date:  1999 Nov-Dec       Impact factor: 3.333

3.  Reverse saphenous conduit flap in the dog.

Authors:  M M Pavletic; J Watters; R W Henry; L A Nafe
Journal:  J Am Vet Med Assoc       Date:  1983-02-15       Impact factor: 1.936

4.  Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).

Authors:  D H Thamm; E A Mauldin; D M Vail
Journal:  J Vet Intern Med       Date:  1999 Sep-Oct       Impact factor: 3.333

5.  Vincristine therapy for mast cell tumors in dogs.

Authors:  D L McCaw; M A Miller; P J Bergman; S J Withrow; A S Moore; D W Knapp; D Fowler; J C Johnson
Journal:  J Vet Intern Med       Date:  1997 Nov-Dec       Impact factor: 3.333

6.  Response of canine mast cell tumors to treatment with oral prednisone.

Authors:  D L McCaw; M A Miller; G K Ogilvie; S J Withrow; W G Brewer; M K Klein; F W Bell; S K Anderson
Journal:  J Vet Intern Med       Date:  1994 Nov-Dec       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.